Business

Former Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health Board

· GlobeWire Daily Business Desk · Source: www.prnewswire.com

2 min read

Key takeawaysFabia Tetteroo-Bueno, the former Senior Vice President and General Manager of Philips Latin America, has been appointed to the Board of Directors of Lapsi Health, the Dutch clinical AI company behind the Keikku platform. The announcement was made in Amsterdam on October 29, 2026, detailing her role in guiding the company's strategy and partnerships as it…
Former Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health Board

Original GlobeWire Daily editorial illustration — not an event photograph.

Fabia Tetteroo-Bueno, the former Senior Vice President and General Manager of Philips Latin America, has been appointed to the Board of Directors of Lapsi Health, the Dutch clinical AI company behind the Keikku platform. The announcement was made in Amsterdam on October 29, 2026, detailing her role in guiding the company's strategy and partnerships as it expands across Latin America.

Tetteroo-Bueno brings more than 20 years of global healthcare leadership experience. Born in Brazil, she built her career across three continents at Royal Philips. In 2020, she became the first woman to lead Philips in Latin America, guiding its healthcare strategy through the COVID-19 pandemic. She subsequently held senior global commercial roles, including Head of Global Sales for the Software business.

Regional Expansion and Offerings

The appointment follows regional developments for Keikku, including an office in Santiago and collaborations with SMC and SOMEIC. Latin America represents one of the platform's fastest-growing markets, featuring three main offerings tailored for Spanish- and Portuguese-speaking clinicians:

  • Keikku Scribe: Ambient AI designed to convert patient conversations into structured clinical notes in real time.
  • Keikku Reference: AI-powered clinical decision support at the point of care.
  • Keikku Telemedicina: Adapted tools specifically for virtual consultations.

Leadership Statements

Jhonatan Bringas Dimitriades, CEO and co-founder of Lapsi Health, stated that Tetteroo-Bueno's appointment marks a turning point as Keikku deepens its regional presence. Tetteroo-Bueno noted her motivation for joining stems from bringing validated, certified clinical technology to Latin America, matching standards found in the U.S. and Europe.

Founded in Amsterdam in 2022, Lapsi Health develops clinical AI platforms combining FDA-cleared ambient microphone systems with AI documentation, clinical reference, and auscultation suites. The company holds ISO 13485 certification, and its AI Scribe carries CE MDR Class I certification, with deployments across Europe and the United States.

Readers can verify original announcements through official press release distributions and Lapsi Health's corporate communications channels.

Share this article
Read the original source: Former Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health / Keikku Board to Lead Latin American Expansion

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Business Desk — AI-assisted news based on attributed published sources.

More to read